Literature DB >> 7593646

Plasma carboxypeptidases as regulators of the plasminogen system.

A Redlitz1, A K Tan, D L Eaton, E F Plow.   

Abstract

Carboxy-terminal lysine residues on the surface of cells and fibrin bind plasminogen and control its activation. Since plasma contains basic carboxypeptidases, which remove carboxy-terminal lysines from protein substrates, we investigated if these enzymes are involved in the regulation of plasminogen binding sites. Plasma reduced plasminogen binding to cells, and this effect could be ascribed to the activity of the plasma carboxypeptidases. Purified carboxypeptidase N, which is constitutively active, and plasma carboxypeptidase B, which circulates as a zymogen, were both capable of significantly reducing plasminogen binding to cells. Dose titration experiments verified that plasma concentrations of either carboxypeptidase were sufficient to maximally affect plasminogen binding to cells. Furthermore, plasma carboxypeptidase B, but not carboxypeptidase N, reduced the rate of whole blood clot lysis induced by tissue-type plasminogen activator. These findings establish that plasma carboxypeptidases can modulate plasminogen binding to cells and control the rate of fibrinolysis. These functions delineate a novel role for the plasma carboxypeptidases in the regulation of the plasminogen system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593646      PMCID: PMC185916          DOI: 10.1172/JCI118315

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Human carboxypeptidase N: lysine carboxypeptidase.

Authors:  R A Skidgel
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen.

Authors:  U Christensen
Journal:  FEBS Lett       Date:  1985-03-11       Impact factor: 4.124

4.  Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation.

Authors:  G A Marguerie; T S Edgington; E F Plow
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

5.  An improved spectrophotometric assay for human plasma carboxypeptidase N1.

Authors:  T H Plummer; M T Kimmel
Journal:  Anal Biochem       Date:  1980-11-01       Impact factor: 3.365

6.  Radioimmunoassay of active pancreatic enzymes in sera from patients with acute pancreatitis. I. Active carboxypeptidase B.

Authors:  A S Delk; P R Durie; T S Fletcher; C Largman
Journal:  Clin Chem       Date:  1985-08       Impact factor: 8.327

7.  Human plasma carboxypeptidase N. Isolation and characterization.

Authors:  T H Plummer; M Y Hurwitz
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

8.  Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.

Authors:  P C Harpel; T S Chang; E Verderber
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

9.  By-product analogues for bovine carboxypeptidase B.

Authors:  T J McKay; T H Plummer
Journal:  Biochemistry       Date:  1978-02-07       Impact factor: 3.162

10.  Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase i).

Authors:  Y Levin; R A Skidgel; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more
  36 in total

Review 1.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

2.  Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.

Authors:  Xinkang Wang; Patricia L Smith; Mei-Yin Hsu; Joseph A Tamasi; Eileen Bird; William A Schumacher
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

3.  Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

Authors:  Mercy O Quagraine; Fulong Tan; Hironori Tamei; Ervin G Erdös; Randal A Skidgel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

Authors:  Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

5.  Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.

Authors:  Jonathan H Foley; Paula Kim; Michael E Nesheim
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

6.  Carboxypeptidases: new regulators of plasminogen activation in vivo?

Authors:  D J Loskutoff
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.

Authors:  M C Minnema; P W Friederich; M Levi; P A von dem Borne; L O Mosnier; J C Meijers; B J Biemond; C E Hack; B N Bouma; H ten Cate
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models.

Authors:  W P Sheffield; L J Eltringham-Smith; S Gataiance; V Bhakta
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

9.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

10.  Dietary zinc depletion and repletion affects plasma proteins: an analysis of the plasma proteome.

Authors:  Arthur Grider; Kathie Wickwire; Emily Ho; Carolyn S Chung; Janet King
Journal:  Biometals       Date:  2012-12-20       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.